Lindsay Stevens

Lindsay has more than 13 years of experience and a specific passion for cutting-edge technology companies. In 2016, Lindsay was instrumental in the launch of the first FDA-approved fertility tracker, Ava. Since then she's worked with healthtech companies ranging from organic women's health products to health and fitness trackers and sexual wellness apps. In the broader tech B2B and B2C space, Lindsay also successfully launched e-commerce sites, startups and apps and handled the execution of numerous funding announcements resulting in top-tier coverage from publications including New York Times, Wired, Business Insider, Fast Company, and the Wall Street Journal. Lindsay joined the Cogenta team in 2022.